NCT00477581 - A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

exenatide

subcutaneous injection (5mcg or 10mcg), twice a day

DRUG

sitagliptin

oral administration (100mg), once a day in the morning

Trial Locations (19)

Research Site, Indianapolis

Research Site, Los Angeles

Research Site, Spring Valley

Research Site, Miami

Research Site, Pembroke Pines

Research Site, Chicago

Research Site, Indianapolis

Research Site, Detroit

Research Site, Butte

Research Site, Winston-Salem

Research Site, Cincinnati

Research Site, Marion

Research Site, Eugene

Research Site, Portland

Research Site, Charleston

Research Site, Greer

Research Site, Austin

Research Site, Corpus Christi

Research Site, San Antonio